| Karen H Albritton, MD | |
|
1500 Cooper St, Fort Worth, TX 76104-2710 | |
| (682) 885-4007 | |
| (682) 885-4004 |
| Full Name | Karen H Albritton |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Pediatric Hematology-oncology |
| Location | 1500 Cooper St, Fort Worth, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982664074 | NPI | - | NPPES |
| Entity Name | Cook Childrens Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750369203 PECOS PAC ID: 7719884584 Enrollment ID: O20040128000800 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services today announced that it has retained Questrade Inc. to provide market making services. The market making service will be undertaken by Questrade in compliance with the guidelines of the TSX Venture Exchange.
Cytopathology researchers at Houston Methodist Hospital recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold.
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a contract from the Defense Advanced Research Projects Agency, a research agency within the U.S. Department of Defense, to find molecular signatures in blood that identify previous exposures and time of exposure to materials that could be associated with weapons of mass destruction (including infectious agents, chemicals, and radiation).
In today's headlines, reports about the super committee's apparent impasse, and details on Mitt Romney's plan to cut the deficit.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen H Albritton, MD Po Box 733784, Dallas, TX 75373-3784 Ph: (682) 885-1855 | Karen H Albritton, MD 1500 Cooper St, Fort Worth, TX 76104-2710 Ph: (682) 885-4007 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services today announced that it has retained Questrade Inc. to provide market making services. The market making service will be undertaken by Questrade in compliance with the guidelines of the TSX Venture Exchange.
Cytopathology researchers at Houston Methodist Hospital recently found that combining two diagnostic tests, Pap and high-risk human papillomavirus (hrHPV), dramatically decreased the chance of missing tumors and high-grade lesions by sevenfold.
Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a contract from the Defense Advanced Research Projects Agency, a research agency within the U.S. Department of Defense, to find molecular signatures in blood that identify previous exposures and time of exposure to materials that could be associated with weapons of mass destruction (including infectious agents, chemicals, and radiation).
In today's headlines, reports about the super committee's apparent impasse, and details on Mitt Romney's plan to cut the deficit.
› Verified 9 days ago
Dr. Heidi Danielle Tomlinson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1301 Pennsylvania Ave, Department Of Neonatology, Fort Worth, TX 76104 Phone: 817-250-2892 | |
Rachel Marie Souers, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-6726 Fax: 682-885-6729 | |
Gregory Barker, Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1500 Cooper St, Fort Worth, TX 76104 Phone: 682-885-2140 Fax: 817-332-2506 | |
Anne Marcum Kirk, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-1475 Fax: 682-885-7520 | |
Hina Aziz Rehman, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1401 W Pulaski St, Fort Worth, TX 76104 Phone: 682-885-8012 Fax: 682-885-8014 | |
Khalid H Syed, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2332 Beverly Hills Dr, Fort Worth, TX 76114 Phone: 817-378-0855 Fax: 817-378-0861 | |
Dr. Phuong Thi Nguyen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 801 7th Ave, Fort Worth, TX 76104 Phone: 682-885-1475 Fax: 682-885-7520 |